98
|
275
|
8pboA |
Deep interactome learning for generative drug design |
100
|
295
|
8ch8A |
Crystal structure of the human pxr ligand-binding domain in complex with liranaftate |
100
|
293
|
8cf9A |
Crystal structure of the human pxr ligand-binding domain in complex with sclareol |
96
|
293
|
8cctA |
Crystal structure of the human pxr ligand-binding domain in complex with 2,2'-dichloro bisphenol a |
656
|
2011
|
7vciS |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
598
|
2011
|
7vopS |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
79
|
630
|
8wg5M |
Cryo-em structure of usp16 bound to h2ak119ub nucleosome |
27
|
111
|
8wg5C |
Cryo-em structure of usp16 bound to h2ak119ub nucleosome |
29
|
98
|
8wg5A |
Cryo-em structure of usp16 bound to h2ak119ub nucleosome |
14
|
76
|
8wg5U |
Cryo-em structure of usp16 bound to h2ak119ub nucleosome |
25
|
79
|
8wg5B |
Cryo-em structure of usp16 bound to h2ak119ub nucleosome |
30
|
94
|
8wg5D |
Cryo-em structure of usp16 bound to h2ak119ub nucleosome |
338
|
1394
|
7vopD |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
392
|
1394
|
7vciD |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
65
|
220
|
7v8pA |
Crystal structure of the muke dimer |
41
|
333
|
7vopC |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
188
|
654
|
7vopU |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
244
|
798
|
7vopH |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
106
|
269
|
7w0gA |
Human ppar delta ligand binding domain in complex with a synthetic agonist h11 |
77
|
209
|
7vopa |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
291
|
1076
|
7vciI |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
221
|
653
|
7vciA |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
209
|
687
|
7vciF |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
52
|
326
|
7vciE |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
58
|
333
|
7vciC |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
39
|
294
|
7vciG |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
267
|
798
|
7vciH |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
57
|
375
|
7vciB |
Structure of xenopus laevis npc nuclear ring asymmetric unit |
175
|
483
|
7t7tA |
Structure of tsk/bru1 bound to histone h3.1 |
0
|
37
|
7t7tW |
Structure of tsk/bru1 bound to histone h3.1 |
55
|
176
|
7ny7A |
Crystal structure of the capsaspora owczarzaki macroh2a macrodomain in complex with adp-ribose |
61
|
189
|
7ny6A |
Crystal structure of the capsaspora owczarzaki macroh2a macrodomain |
261
|
1076
|
7vopI |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
242
|
772
|
7vopV |
Cryo-em structure of xenopus laevis nuclear pore complex cytoplasmic ring subunit |
82
|
236
|
7qdtA |
Crystal structure of a mutant (p393gx) thyroid receptor alpha ligand binding domain designed to model dominant negative human mutations. |
319
|
1217
|
7q4oC |
Substrate-bound a-like u2 snrnp |
22
|
90
|
7q4oF |
Substrate-bound a-like u2 snrnp |
10
|
41
|
7q4o1 |
Substrate-bound a-like u2 snrnp |
25
|
101
|
7q4p9 |
U2 snrnp after atp-dependent remodelling |
19
|
70
|
7q3lE |
Human 17s u2 snrnp 5' domain |
317
|
1217
|
7q3lC |
Human 17s u2 snrnp 5' domain |
16
|
81
|
7q3lG |
Human 17s u2 snrnp 5' domain |
32
|
97
|
7q3l9 |
Human 17s u2 snrnp 5' domain |
19
|
65
|
7q4oE |
Substrate-bound a-like u2 snrnp |
17
|
255
|
7q4pB |
U2 snrnp after atp-dependent remodelling |
19
|
64
|
7q4pE |
U2 snrnp after atp-dependent remodelling |
335
|
814
|
7q3lA |
Human 17s u2 snrnp 5' domain |
16
|
81
|
7q4oG |
Substrate-bound a-like u2 snrnp |
320
|
911
|
7q4oA |
Substrate-bound a-like u2 snrnp |
22
|
260
|
7q3lB |
Human 17s u2 snrnp 5' domain |